These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Current HIV/SIV Reservoir Assays for Preclinical and Clinical Applications: Recommendations from the Experts 2022 NIAID Workshop Summary. Sanders-Beer BE; Archin NM; Brumme ZL; Busch MP; Deleage C; O'Doherty U; Hughes SH; Jerome KR; Jones RB; Karn J; Kearney MF; Keele BF; Kulpa DA; Laird GM; Li JZ; Lichterfeld MD; Nussenzweig MC; Persaud D; Yukl SA; Siliciano RF; Mellors JW AIDS Res Hum Retroviruses; 2023 Jun; ():. PubMed ID: 37126090 [TBL] [Abstract][Full Text] [Related]
28. The Role of Macrophages in HIV-1 Persistence and Pathogenesis. Kruize Z; Kootstra NA Front Microbiol; 2019; 10():2828. PubMed ID: 31866988 [TBL] [Abstract][Full Text] [Related]
29. Establishment of a Novel Humanized Mouse Model To Investigate Flerin NC; Bardhi A; Zheng JH; Korom M; Folkvord J; Kovacs C; Benko E; Truong R; Mota T; Connick E; Jones RB; Lynch RM; Goldstein H J Virol; 2019 Mar; 93(6):. PubMed ID: 30626677 [TBL] [Abstract][Full Text] [Related]
30. Clinical pharmacology in HIV cure research - what impact have we seen? Giacomelli A; de Rose S; Rusconi S Expert Rev Clin Pharmacol; 2019 Jan; 12(1):17-29. PubMed ID: 30570410 [No Abstract] [Full Text] [Related]
31. The Alphabet Soup of HIV Reservoir Markers. Sharaf RR; Li JZ Curr HIV/AIDS Rep; 2017 Apr; 14(2):72-81. PubMed ID: 28401492 [TBL] [Abstract][Full Text] [Related]
32. Vaccine and immunotherapeutic interventions. Pantaleo G; Lévy Y Curr Opin HIV AIDS; 2013 May; 8(3):236-42. PubMed ID: 23478912 [TBL] [Abstract][Full Text] [Related]
33. Highlights from the Third Biennial Strategies for an HIV Cure Meeting: 14-16 November 2016, Bethesda, MD, USA. Lawrence D; Kuo L; Church E; Poon B; Smiley S; Sanders-Beer B; Dawson L; Salzwedel K J Virus Erad; 2017 Jan; 3(1):69-76. PubMed ID: 28275462 [TBL] [Abstract][Full Text] [Related]
34. Regulatory T cells: the ultimate HIV reservoir? Rocco J; Mellors JW; Macatangay BJ J Virus Erad; 2018 Oct; 4(4):209-214. PubMed ID: 30515299 [TBL] [Abstract][Full Text] [Related]
35. The microbiome and HIV persistence: implications for viral remission and cure. Koay WLA; Siems LV; Persaud D Curr Opin HIV AIDS; 2018 Jan; 13(1):61-68. PubMed ID: 29135490 [TBL] [Abstract][Full Text] [Related]
36. Immune interventions in HIV infection. Carcelain G; Autran B Immunol Rev; 2013 Jul; 254(1):355-71. PubMed ID: 23772631 [TBL] [Abstract][Full Text] [Related]
37. When is Early Antiretroviral Therapy Early Enough for HIV Remission? Poveda E; Crespo M AIDS Rev; 2017; 19(2):113-114. PubMed ID: 28534887 [TBL] [Abstract][Full Text] [Related]
38. Antibodies and Antibody Derivatives: New Partners in HIV Eradication Strategies. Carrillo J; Clotet B; Blanco J Front Immunol; 2018; 9():2429. PubMed ID: 30405624 [TBL] [Abstract][Full Text] [Related]
39. Cat and Mouse: HIV Transcription in Latency, Immune Evasion and Cure/Remission Strategies. Delannoy A; Poirier M; Bell B Viruses; 2019 Mar; 11(3):. PubMed ID: 30889861 [TBL] [Abstract][Full Text] [Related]